Concord Biotech Ltd

Common Name
Concord Biotech
Country
India
Sector
Healthcare
Industry
Biotechnology
Employees
1,571
Ticker
CONCORDBIO
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Concord Biotech Ltd. is an innovative biopharmaceutical company engaged in the research, development, and manufacture of biopharmaceutical ingredients and products. Primarily focused on the pharmaceut...

Concord Biotech's GHG Emissions Data Preview

In 2025, Concord Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Concord Biotech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Concord Biotech’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Concord Biotech’s data sources below and access millions more through our Disclosure Search.

a. Concord Biotech's Annual Report 2025
a. Concord Biotech's Annual Report 2025

Insights into Concord Biotech's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Concord Biotech amounted to 12.534 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Concord Biotech decreased by 99.98%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Concord Biotech's Scope 1 Emissions Over Time

2024202504 k8 k12 k16 ktCO2e-100%
  • Total Scope 1
  • Year-over-Year Change

What are Concord Biotech's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Concord Biotech were 12.511 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2024), Concord Biotech's Scope 1 emissions decreased by 99.91%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Concord Biotech's Scope 2 emissions?

In 2025, Concord Biotech reported Scope 2 greenhouse gas (GHG) emissions of 0.023 tCO₂e without specifying the calculation method. a

Has Concord Biotech reduced its Scope 2 emissions over time?

Compared to the previous year (2024), Concord Biotech's Scope 2 emissions (Unspecified Calculation Method) fell by 100% in 2025, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a

What methodology does Concord Biotech use for Scope 2 reporting?

In 2025, Concord Biotech reported its Scope 2 emissions using an unspecified methodology. a

Concord Biotech's Scope 2 Emissions Over Time

20242025015 k30 k45 k60 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Concord Biotech’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Concord Biotech reported Scope 1 greenhouse gas (GHG) emissions of 12.511 tCO₂e and total revenues of USD 138 millions. This translates into an emissions intensity of 0.09 tCO₂e per millions USD. a

Concord Biotech's Scope 1 Emissions Intensity Compared to Peers

101002,00020,000500,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)BOJCBBBlue Jet HealthcareYear: 2025Scope 1: 23,877 tCO2eRevenue: $M 120Scope 1 Intensity: 198.82 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$MBioconYear: 2025Scope 1: 27,951 tCO2eRevenue: $M 1,762Scope 1 Intensity: 15.87 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MSyngene InternationalYear: 2024Scope 1: 6,653 tCO2eRevenue: $M 404Scope 1 Intensity: 16.47 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MCohance LifesciencesYear: 2025Scope 1: 31,818 tCO2eRevenue: $M 140Scope 1 Intensity: 227.00 tCO2e/$MOOOrchid PharmaYear: 2025Scope 1: 74,800 tCO2eRevenue: $M 108Scope 1 Intensity: 693.22 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MPoly MedicureYear: 2025Scope 1: 3,338 tCO2eRevenue: $M 195Scope 1 Intensity: 17.08 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MFortis HealthcareYear: 2025Scope 1: 4,600 tCO2eRevenue: $M 904Scope 1 Intensity: 5.09 tCO2e/$MSun Pharmaceutical IndustriesYear: 2025Scope 1: 156,242 tCO2eRevenue: $M 6,091Scope 1 Intensity: 25.65 tCO2e/$MApollo Hospitals EnterpriseYear: 2023Scope 1: 8,033 tCO2eRevenue: $M 2,003Scope 1 Intensity: 4.01 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MNarayana HrudayalayaYear: 2025Scope 1: 17,923 tCO2eRevenue: $M 642Scope 1 Intensity: 27.93 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MCCConcord BiotechYear: 2025Scope 1: 13 tCO2eRevenue: $M 138Scope 1 Intensity: 0.09 tCO2e/$M

How does Concord Biotech's GHG emissions intensity compare to its peers?

In 2025, Concord Biotech reported a Scope 1 emissions intensity of 0.09 tCO₂e per millions USD. Compared to the peer group median of 22.24 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Concord Biotech rank on GHG emissions intensity within its industry?

In 2025, Concord Biotech ranked 1 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Concord Biotech among the top performers, with one of the lowest emissions intensities relative to peers. a

Want Full Access to Concord Biotech's GHG Emissions Dataset?
Sign Up